Prevalent use of Combined Prophylaxis of Hepatitis B after liver transplantation in Italy: Results of a national survey in a large cohort

A. Marzano, P. Andreone, P. Boccagni, P. Burra, F. Caneschi, P.F. Conoscitore, C. Coppola, L. De Carlis, S. Fagiuoli, P. Forte, G.B. Gaeta, R.M. Iemmolo, A.L. Suffredini, M. Mazzola, M. Merli, G. Parrilli, G. Piai, M.R. Piras, M. Salizzoni, M. TamèG. Tisone, P. Toniutto, G. Vennarecci, R. Volpes, F. Zamboni, L. Caccamo, V.R. Bertuzzo, A.S. Bongiovanni, G. Brin-Dicci, D. Cocchis, G.M. Ettorre, E. Gianni, M. Giusto, I. Lenisa, M.G. Lucà, L. Mameli, I. Mangoni, M.A. Manini, S. Paoli, F.P. Russo, L. Staiano, G. Stornaiuolo, L. Toti, G. Valente, R. Vukotic, ISPHEB Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalMinerva Gastroenterologica e Dietologica
Issue number1
Publication statusPublished - 2018


  • entecavir
  • hepatitis B antibody
  • hepatitis B core antibody
  • hepatitis B surface antigen
  • immunoglobulin
  • lamivudine, Article
  • clinical evaluation
  • controlled study
  • hepatitis B
  • Hepatitis delta virus
  • human
  • immune status
  • Italy
  • liver cell carcinoma
  • liver transplantation
  • major clinical study
  • mixed infection
  • multicenter study
  • nonhuman
  • physician
  • prevalence
  • prophylaxis
  • questionnaire

Cite this